Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice

Inflammatory bowel disease (IBD) results from dysregulation of intestinal mucosal immune responses to microflora in genetically susceptible hosts. A major challenge for IBD research is to develop new strategies for treating this disease. Berberine, an alkaloid derived from plants, is an alternative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yan, Fang, Wang, Lihong, Shi, Yan, Cao, Hanwei, Liu, Liping, Washington, M. Kay, Chaturvedi, Rupesh, Israel, Dawn A., Cao, Hailong, Wang, Bangmao, Peek, Richard M., Wilson, Keith T., Polk, D. Brent
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2012
Matèries:
Inflammation/Immunity/Mediators
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3311435/
https://ncbi.nlm.nih.gov/pubmed/22173918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpgi.00312.2011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars